Media Room

/assets/dotcom/content-app/events/banner-investors-events_20230703194346.jpg

First Quarter 2025

First quarter 2025 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.

Thursday April 24, 2025

Press releases


May 27, 2025
Press Release: Sanofi completes acquisition of DR-0201

May 21, 2025
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline

May 1, 2025
Media Update: ATS: Sanofi showcases leadership and breadth of scientific innovation in chronic inflammatory respiratory conditions

Contact Our Media Team

You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.

Publications

Sustainability Statement 2024 (ESG Report)
Download PDF
XBRL Viewer URD 2024
Download PDF
XBRL Viewer 20F 2024
Download PDF
Registration Document 2024 (in French)
Download PDF